These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 9794381

  • 1. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses.
    Qin D, Wu J, Carroll MC, Burton GF, Szakal AK, Tew JG.
    J Immunol; 1998 Nov 01; 161(9):4549-54. PubMed ID: 9794381
    [Abstract] [Full Text] [Related]

  • 2. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response.
    Fang Y, Xu C, Fu YX, Holers VM, Molina H.
    J Immunol; 1998 Jun 01; 160(11):5273-9. PubMed ID: 9605124
    [Abstract] [Full Text] [Related]

  • 3. Follicular dendritic cell-derived antigen and accessory activity in initiation of memory IgG responses in vitro.
    Wu J, Qin D, Burton GF, Szakal AK, Tew JG.
    J Immunol; 1996 Oct 15; 157(8):3404-11. PubMed ID: 8871638
    [Abstract] [Full Text] [Related]

  • 4. Age-related depression of FDC accessory functions and CD21 ligand-mediated repair of co-stimulation.
    Aydar Y, Balogh P, Tew JG, Szakal AK.
    Eur J Immunol; 2002 Oct 15; 32(10):2817-26. PubMed ID: 12355434
    [Abstract] [Full Text] [Related]

  • 5. Follicular dendritic cells and the maintenance of IgE responses.
    Helm SL, Burton GF, Szakal AK, Tew JG.
    Eur J Immunol; 1995 Aug 15; 25(8):2362-9. PubMed ID: 7664798
    [Abstract] [Full Text] [Related]

  • 6. [Role of the complement C3 protein in the control of the specific immune response].
    Villiers CL, Villiers MB, Marche PN.
    Ann Biol Clin (Paris); 1999 Aug 15; 57(2):127-35. PubMed ID: 10210739
    [Abstract] [Full Text] [Related]

  • 7. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells.
    Boackle SA, Morris MA, Holers VM, Karp DR.
    J Immunol; 1998 Dec 15; 161(12):6537-43. PubMed ID: 9862679
    [Abstract] [Full Text] [Related]

  • 8. Impaired antibody responses but normal proliferation of specific CD4+ T cells in mice lacking complement receptors 1 and 2.
    Carlsson F, Getahun A, Rutemark C, Heyman B.
    Scand J Immunol; 2009 Aug 15; 70(2):77-84. PubMed ID: 19630912
    [Abstract] [Full Text] [Related]

  • 9. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
    Kulik L, Chen K, Huber BT, Holers VM.
    Mol Immunol; 2011 Mar 15; 48(6-7):883-94. PubMed ID: 21269698
    [Abstract] [Full Text] [Related]

  • 10. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
    Kozono Y, Abe R, Kozono H, Kelly RG, Azuma T, Holers VM.
    J Immunol; 1998 Feb 15; 160(4):1565-72. PubMed ID: 9469411
    [Abstract] [Full Text] [Related]

  • 11. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line.
    Hatzfeld A, Fischer E, Levesque JP, Perrin R, Hatzfeld J, Kazatchkine MD.
    J Immunol; 1988 Jan 01; 140(1):170-5. PubMed ID: 2826586
    [Abstract] [Full Text] [Related]

  • 12. T-independent antibody responses to T-dependent antigens: a novel follicular dendritic cell-dependent activity.
    El Shikh ME, El Sayed RM, Szakal AK, Tew JG.
    J Immunol; 2009 Mar 15; 182(6):3482-91. PubMed ID: 19265126
    [Abstract] [Full Text] [Related]

  • 13. Follicular dendritic cells and B cell costimulation.
    Burton GF, Conrad DH, Szakal AK, Tew JG.
    J Immunol; 1993 Jan 01; 150(1):31-8. PubMed ID: 8417129
    [Abstract] [Full Text] [Related]

  • 14. Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction.
    Gustavsson S, Kinoshita T, Heyman B.
    J Immunol; 1995 Jun 15; 154(12):6524-8. PubMed ID: 7759885
    [Abstract] [Full Text] [Related]

  • 15. Complement receptors CD21 and CD35 in humoral immunity.
    Roozendaal R, Carroll MC.
    Immunol Rev; 2007 Oct 15; 219():157-66. PubMed ID: 17850488
    [Abstract] [Full Text] [Related]

  • 16. Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant.
    Mattsson J, Yrlid U, Stensson A, Schön K, Karlsson MC, Ravetch JV, Lycke NY.
    J Immunol; 2011 Oct 01; 187(7):3641-52. PubMed ID: 21880985
    [Abstract] [Full Text] [Related]

  • 17. Complement's participation in acquired immunity.
    Nielsen CH, Leslie RG.
    J Leukoc Biol; 2002 Aug 01; 72(2):249-61. PubMed ID: 12149415
    [Abstract] [Full Text] [Related]

  • 18. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection.
    Kopf M, Abel B, Gallimore A, Carroll M, Bachmann MF.
    Nat Med; 2002 Apr 01; 8(4):373-8. PubMed ID: 11927943
    [Abstract] [Full Text] [Related]

  • 19. CD21 augments antigen presentation in immune individuals.
    Boackle SA, Holers VM, Karp DR.
    Eur J Immunol; 1997 Jan 01; 27(1):122-9. PubMed ID: 9022008
    [Abstract] [Full Text] [Related]

  • 20. A novel mechanism of alternative pathway complement activation accounts for the deposition of C3 fragments on CR2-expressing homologous cells.
    Schwendinger MG, Spruth M, Schoch J, Dierich MP, Prodinger WM.
    J Immunol; 1997 Jun 01; 158(11):5455-63. PubMed ID: 9164968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.